Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

Eur Heart J. 2010 Oct;31(19):2369-429. doi: 10.1093/eurheartj/ehq278. Epub 2010 Aug 29.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Acute Coronary Syndrome / complications
  • Acute Coronary Syndrome / therapy
  • Adult
  • Aged
  • Angioplasty, Balloon, Coronary / methods
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / etiology
  • Atrial Fibrillation* / therapy
  • Catheter Ablation / methods
  • Electric Countershock / methods
  • Electrocardiography
  • Fibrinolytic Agents / therapeutic use
  • Heart Failure / etiology
  • Heart Valve Diseases / complications
  • Hemorrhage / chemically induced
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • International Normalized Ratio
  • Intraoperative Care
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Point-of-Care Systems
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy
  • Precision Medicine
  • Primary Prevention
  • Quality of Life
  • Recurrence
  • Risk Assessment
  • Secondary Prevention
  • Sports
  • Stroke / prevention & control
  • Thromboembolism / etiology
  • Ventricular Dysfunction, Left / etiology

Substances

  • Anti-Arrhythmia Agents
  • Fibrinolytic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Mineralocorticoid Receptor Antagonists
  • Platelet Aggregation Inhibitors